Skip to nav Skip to content

News

May 15, 2019

 All Issues
 Read the last issue of IDSA News Read the next issue of IDSA News 
IDSA Inaugural Leadership Institute

IDSA gathered 30 diverse leaders from across the United States (and Malawi) for the launch of the inaugural IDSA Leadership Institute in early May. 

Read More
A Journey Toward Inclusion, Diversity, Access & Equity at IDSA

Many medical specialties have acknowledged disparities in their healthcare workforce and have made strategic changes to address diversity and inclusion as an innovation challenge for their medical societies.

Read More
Volunteer Opportunity – IDSA Clinical Fellows Meeting Planning Group

Last month, over 100 fellows interested in pursuing a career in clinical practice participated in the annual IDSA Clinical Fellows Meeting. Read about what the meeting entails and how you can get involved.

Read More
Urge CMS to Improve Antibiotic Reimbursement and Stewardship

The announcement of the bankruptcy of Achaogen, the small company that developed plazomicin, underscores the urgent need for the federal government to protect and strengthen the antibiotic pipeline.

Read More
Journal Club

In this feature, a panel of IDSA members identifies and critiques important new studies in the current literature that have a significant impact on the practice of infectious diseases medicine. 
Reviews in this issue: Is Vancomycin Really Preferred Over Metronidazole for Mild C. difficile Infection? and Marijuana for People Living with HIV and Chronic Pain

Read More
JID Supplement Call for Manuscripts: Infectious Diseases and Injection Drug Use

The Journal of Infectious Diseases (JID) and the US Centers for Disease Control (CDC) are inviting submissions for a thematic supplement titled “Infectious Diseases and Injection Drug Use: Public Health Burden and Response.”

Read More
ID and HIV Programs Get Boost in House Funding Bill

The House Appropriations Committee passed its FY2020 Labor, Health, and Human Services funding bill on May 8, addressing key concerns of IDSA/HIVMA members who have advocated for deeper investments in ID and HIV prevention, care and research.

Read More
Evaluation and Management CPT® Codes Update

IDSA members and staff attended a recent meeting of the American Medical Association’s Relative Value Scale Update Committee (RUC) to ensure that concerns of the infectious diseases community are considered as relative work values are assigned to revised CPT® codes.

Read More
IDSA Shares Priorities with US Delegation Ahead of World Health Assembly

IDSA was invited to deliver statements to officials from the Department of Health and Human Services and Department of State ahead of the World Health Assembly, May 20 – 28 in Geneva, Switzerland. 

Read More
IDSA Gives Congressional Staff First-Hand Glimpse at Outbreak Response

IDSA recently hosted an interactive event on Capitol Hill to educate congressional staff on the need to fully fund U.S. efforts to strengthen global capacities to prevent, detect and respond to infectious disease threats where they originate. 

Read More
HHS Office of HIV and ID Policy Wants Input on Responding to Surge in STIs

The U.S. Department of Health & Human Services Office of HIV/AIDS and Infectious Disease Policy has published a Request for Information (RFI) in the Federal Register seeking written comments and recommendations for a Federal Action Plan responding to the surge of sexually transmitted infections, including strategies to improve the efficiency, effectiveness, coordination, accountability, and impact of the federal response.  

Read More
IDSA Member Appointed to Tick-borne Disease Working Group

IDSA member Eugene Shapiro, MD, FIDSA has been selected to serve on the second session of Department of Health and Human Service’s (HHS) Tick-borne Disease Working Group, which resumes its activities with an in-person meeting in Washington, DC on June 4. IDSA engagement in this group is essential to promote evidence-based approaches to treating tick-borne diseases.

Read More
“Public Charge” News that May Affect Your Patients

The administration is expected to soon release updated rules and proposed rules related to when an immigrant who is a legal U.S. resident may be considered a “public charge,” affecting their ability to enter or stay in the U.S. 

Read More
Science Speaks Follows Ebola Research, Developments

The IDSA/HIVMA Science Speaks blog continued coverage of the current Ebola outbreak in the Democratic Republic of Congo and findings from the 2013-2016 West Africa crisis.

Read More
From HIV to Antibiotic Resistance and MMR Vaccine, IDSA Experts Gain National Media Coverage

As Congress decides funding priorities for the year ahead, HIVMA Chair Dr. W. David Hardy wrote this opinion piece in The Baltimore Sun on the work, resources and policies needed to reach the administration’s stated goal of ending HIV as an epidemic.

Read More
ICYMI: What’s Hot on MyIDSA

Here’s a glance at the latest discussions happening on MyIDSA, IDSA’s members-only online community (login required).

Read More

This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.